Bromonordiazepam Blister – 10x 2.5mg

A. Introduction

Bromonordiazepam Blister 10x 2.5mg is a premium laboratory-grade research chemical containing desalkyl-gidazepam metabolite analog, designed for scientific institutions and analytical laboratories investigating benzodiazepine standards. This high-purity blister format provides researchers with consistent 2.5mg units for multi-point calibration curves, metabolic profiling, and quantitative analysis in controlled settings.

B. Scientific Overview

Bromonordiazepam belongs to the 1,4-benzodiazepine class characterized by its 7-bromo-5-phenyl scaffold suitable for analytical profiling. In research contexts, it functions as an analytical reference for studying chromatographic retention, mass spectrometry transitions, and UV absorbance characteristics of brominated benzodiazepine structures.

Laboratory investigations focus on its chemical properties, including solubility profiles, thermal stability, and quantitative recovery under bioanalytical conditions, without reference to biological interactions.

C. Product Specifications

• Form: Blister-packed units containing 2.5mg bromonordiazepam per tablet (10 tablets per pack)

• Label per unit: 2.5mg analytical portions in tamper-evident blister packaging

• Synonym: 7-Bromo-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

• CAS Number: 2894-61-3

• Molecular Formula: C₁₅H₁₁BrN₂O

• Molecular Weight: 315.16 g/mol

• Purity: ≥98% (HPLC, typical batch purity)

• Storage Conditions: Cool, dry place (2-8°C recommended), protected from light/moisture for stability

D. Laboratory Use Context

Bromonordiazepam Blister 10x 2.5mg is designated solely for in-vitro analytical research, including multi-point reference standard preparation, LC-MS/MS method optimization for benzodiazepine metabolites, forensic toxicology confirmation, and therapeutic drug monitoring validation.

Researchers utilize the 10×2.5mg format for replicate analysis, stability indicating studies, and matrix effect evaluation using techniques such as SPE-LC-MS/MS, GC-NPD, and fluorescence detection. All applications must adhere to institutional laboratory safety standards and regulatory guidelines.

E. Quality & Testing

Every batch receives comprehensive quality control:

• Certificate of Analysis (COA) with HPLC, LC-MS/MS, NMR identity confirmation and content uniformity testing

• Full batch traceability from synthesis through tablet compression and blister sealing

• Third-party laboratory verification of purity, dissolution profile, and absence of process-related impurities

• Manufactured under controlled conditions ensuring consistent tablet potency (±3% RSD) and long-term stability

F. Shipping & Handling

Discreet worldwide shipping to verified research laboratories via secure, compliant carriers. Blister packaging provides inherent protection meeting IATA/DOT standards for benzodiazepine research chemicals, with full documentation for customs clearance. Tracking provided; buyers confirm jurisdictional import compliance prior to purchase.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is supplied strictly as a laboratory reagent for analytical and research purposes only. It receives no approval for human, veterinary, diagnostic, or therapeutic use. No claims regarding pharmacological activity beyond controlled in-vitro analytical contexts.

Qualified researchers and institutions assume complete responsibility under applicable local, federal, and international regulations. Seller disclaims liability for misuse or diversion from authorized laboratory applications.